Compare Dolby Laboratories, Inc. (DLB) vs 8x8 Inc (EGHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs 8x8 Inc — how do they compare? Dolby Laboratories, Inc. trades at $58.9 (market cap $5.47B), while 8x8 Inc trades at $2.2 (market cap $311.98M). The key difference: Dolby Laboratories, Inc. is far larger — about 17.5× 8x8 Inc's market cap, and Dolby Laboratories, Inc. pays a 2.46% dividend while 8x8 Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and 8x8 Inc for 16 Days on average.
| DLB | EGHT | |
|---|---|---|
Market Cap | $5.47B | $311.98M |
Volume | 1,058,284 | 1,639,086 |
Sector | Technology | Technology |
52-Week High | $70.09 | $2.76 |
52-Week Low | $48.51 | $1.59 |
Typical Hold Time | 98 Days | 16 Days |
Enterprise Value | $4.85B | $578.90M |
Dividend Yield | 2.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $58.35, down 0.19% with bearish technical signals. The company maintains strong profitability with 87.61% gross margins and has beaten earnings estimates for three consecutive quarters. Recent developments include expanded partnerships with Meta and leadership transition to new CEO Marc Whitten. Cash flow improved significantly in 2025 with $472M operating cash flow.
DLB presents a mixed outlook with strong fundamentals but technical weakness. The 47% upside to $90.33 consensus target offers potential, though near-term execution risks and licensing volatility remain concerns. Revenue stability around $1.3B and premium valuation metrics require continued innovation execution to justify current multiples.
EGHT trades at $2.14, down 1.38% on the day. The stock exhibits a bullish technical signal with positive moving averages, while recent earnings have consistently beaten expectations. Revenue for 2025 was $715.07M, though the company reported a net loss of $27.21M. Positive news includes a 50% cost reduction for a major client using its platform and recent industry award recognition, highlighting operational strengths.
The outlook is mixed; analyst consensus is a Buy with a $19.77 price target, signaling significant upside potential. However, high debt levels and thin net margins pose risks. The projected return to profitability in 2026 is a key catalyst, but execution risks and competitive pressures in the cloud communications sector remain concerns for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About 8x8 Inc
8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.
Read more on EGHT →
